← All trials
NCT06348797
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 10, 2025
- Primary completion
- Jun 30, 2026
- Completion date
- Dec 31, 2026
- First posted
- Apr 5, 2024
- Last posted
- Oct 30, 2024
- Enrollment
- 28
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sichuan UniversityLead sponsor
- Government of ChinaCollaborator
- Sichuan UniversityOfficial
- Sichuan UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.